Niagen Bioscience

Forecast & Rating6 analysts currently cover Niagen Bioscience, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $12.08, about 281.2% upside from the current price of $3.17. Price targets range from $8.50 to $22.00 — a wide spread, showing clear disagreement over just how much Niagen Bioscience can rise. Historically, about 47.5% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Niagen Bioscience closely still see room for the stock to rise. Data as of Aug 12, 2026; for reference only and not investment advice.